Literature DB >> 24715490

Neurology and the Global HIV Epidemic.

Ana-Claire Meyer1.   

Abstract

The vast majority of people living with human immunodeficiency virus (HIV) infection reside in resource-limited settings. As compared with resource-rich settings, there are important differences in the epidemiology and outcomes of HIV infection in resource-limited settings. Nonetheless, little HIV neurology research occurs in these regions. We will first review clinical, epidemiological, and translational HIV neurology research originating from resource-limited settings. We will then discuss the barriers to conducting neurologic research, such as limited human resources, diagnostics, and access to medications. Finally, we will review existing initiatives to build capacity for research in resource-limited settings. Despite the barriers, there is growing interest in and opportunities for collaborative international neurologic research. Including diverse viral and human populations from across the globe in research opens possibilities for important implementation science, clinically oriented science, and basic science discoveries. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2014        PMID: 24715490      PMCID: PMC4350261          DOI: 10.1055/s-0034-1372344

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  89 in total

1.  Education effects on the International HIV Dementia Scale.

Authors:  Drenna Waldrop-Valverde; Ritu Nehra; Sunil Sharma; Ashima Malik; Deborah Jones; Adarsh M Kumar; Raymond L Ownby; Ajay Wanchu; Steve Weiss; Sudesh Prabhakar; Mahendra Kumar
Journal:  J Neurovirol       Date:  2010-07       Impact factor: 2.643

2.  Characterization of HIV-Associated Neurocognitive Disorders among individuals starting antiretroviral therapy in South Africa.

Authors:  John A Joska; Jennifer Westgarth-Taylor; Landon Myer; Jacqueline Hoare; Kevin G F Thomas; Marc Combrinck; Robert H Paul; Dan J Stein; Alan J Flisher
Journal:  AIDS Behav       Date:  2011-08

3.  An initial screening for HIV-associated neurocognitive disorders of HIV-1 infected patients in China.

Authors:  Yulin Zhang; Luxin Qiao; Wei Ding; Feili Wei; Qingxia Zhao; Xicheng Wang; Ying Shi; Ning Li; Davey Smith; Dexi Chen
Journal:  J Neurovirol       Date:  2012-03-13       Impact factor: 2.643

4.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.

Authors:  Michael C Thigpen; Poloko M Kebaabetswe; Lynn A Paxton; Dawn K Smith; Charles E Rose; Tebogo M Segolodi; Faith L Henderson; Sonal R Pathak; Fatma A Soud; Kata L Chillag; Rodreck Mutanhaurwa; Lovemore Ian Chirwa; Michael Kasonde; Daniel Abebe; Evans Buliva; Roman J Gvetadze; Sandra Johnson; Thom Sukalac; Vasavi T Thomas; Clyde Hart; Jeffrey A Johnson; C Kevin Malotte; Craig W Hendrix; John T Brooks
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

5.  Neuroimaging markers of human immunodeficiency virus infection in South Africa.

Authors:  Jodi M Heaps; John Joska; Jackie Hoare; Mario Ortega; Aleena Agrawal; Soraya Seedat; Beau M Ances; Dan J Stein; Robert Paul
Journal:  J Neurovirol       Date:  2012-04-12       Impact factor: 2.643

6.  Neurological profile and neurodevelopment of 88 children infected with HIV and 84 seroreverter children followed from 1995 to 2002.

Authors:  Tony Tannous Tahan; Isac Bruck; Marion Burger; Cristina Rodrigues Cruz
Journal:  Braz J Infect Dis       Date:  2006-10       Impact factor: 1.949

7.  Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.

Authors:  N Sacktor; N Nakasujja; R Skolasky; K Robertson; M Wong; S Musisi; A Ronald; E Katabira
Journal:  Neurology       Date:  2006-07-25       Impact factor: 9.910

8.  The International HIV Dementia Scale is a useful screening tool for HIV-associated dementia/cognitive impairment in HIV-infected adults in Yaoundé-Cameroon.

Authors:  Alfred K Njamnshi; Vincent de Paul Djientcheu; Julius Y Fonsah; Faustin N Yepnjio; Dora M Njamnshi; Walinjom E Muna
Journal:  J Acquir Immune Defic Syndr       Date:  2008-12-01       Impact factor: 3.731

9.  WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings.

Authors:  M Maj; P Satz; R Janssen; M Zaudig; F Starace; L D'Elia; B Sughondhabirom; M Mussa; D Naber; D Ndetei
Journal:  Arch Gen Psychiatry       Date:  1994-01

10.  HIV-associated neurocognitive disorders (HAND) in a South Asian population - contextual application of the 2007 criteria.

Authors:  Lai Gwen Chan; Nagaendran Kandiah; Arlene Chua
Journal:  BMJ Open       Date:  2012-02-13       Impact factor: 2.692

View more
  5 in total

1.  Use of Western Neuropsychological Test Battery in Detecting HIV-Associated Neurocognitive Disorders (HAND) in Zambia.

Authors:  Norma Kabuba; J Anitha Menon; Donald R Franklin; Robert K Heaton; Knut A Hestad
Journal:  AIDS Behav       Date:  2017-06

2.  Socioeconomic Status and Cognitive Function in Children With HIV: Evidence From the HIV-Associated Neurocognitive Disorders in Zambia (HANDZ) Study.

Authors:  Esau G Mbewe; Pelekelo P Kabundula; Sylvia Mwanza-Kabaghe; Alexandra Buda; Heather R Adams; Colleen Schneider; Michael J Potchen; Milimo Mweemba; Manoj Mathews; J Anitha Menon; Bo Wang; Travis Baseler; Alex Paciorkowski; Gretchen L Birbeck; David R Bearden
Journal:  J Acquir Immune Defic Syndr       Date:  2022-01-01       Impact factor: 3.771

3.  HIV-associated cognitive performance and psychomotor impairment in a Thai cohort on long-term cART.

Authors:  Tanya C Do; Stephen J Kerr; Anchalee Avihingsanon; Saowaluk Suksawek; Supalak Klungkang; Taweesak Channgam; Christoph C Odermatt; Wirach Maek-A-Nantawat; Kiat Ruxtungtham; Jintanat Ananworanich; Victor Valcour; Peter Reiss; Ferdinand W Wit
Journal:  J Virus Erad       Date:  2018-01-01

Review 4.  Neurological disorders in HIV in Africa: a review.

Authors:  William P Howlett
Journal:  Afr Health Sci       Date:  2019-06       Impact factor: 0.927

5.  Interpersonal psychotherapy for depression and posttraumatic stress disorder among HIV-positive women in Kisumu, Kenya: study protocol for a randomized controlled trial.

Authors:  Chinwe Onu; Linnet Ongeri; Elizabeth Bukusi; Craig R Cohen; Thomas C Neylan; Patrick Oyaro; Grace Rota; Faith Otewa; Kevin L Delucchi; Susan M Meffert
Journal:  Trials       Date:  2016-02-03       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.